Title : The impact of FLT3 mutations on treatment response and survival in Chinese de novo AML patients.

Pub. Date : 2018 Apr

PMID : 28876197






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 This study was aimed to analyze the impacts of these mutations on clinical outcomes, and assess the efficacy of different therapeutic regimens (allo-HSCT, sorafenib, or conventional chemotherapy) for AML patients with FLT3 mutations after the standard induction therapy. Sorafenib fms related receptor tyrosine kinase 3 Homo sapiens